Affiliations 

  • 1 The University of Queensland, Centre for Clinical Research (UQCCR), Herston QLD 4029, Australia
  • 2 Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Australia
  • 3 Pathology and Laboratory Medicine Department at Sheikh Khalifa General Hospital, Umm Al Quwain, United Arab Emirates
  • 4 Urology Department, Sheikh Khalifa General Hospital, Umm Al Quwain, United Arab Emirates
  • 5 Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
  • 6 Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia
Sci Rep, 2015;5:15082.
PMID: 26478520 DOI: 10.1038/srep15082

Abstract

Carbapenem resistant Enterobacteriaceae (CRE) pose an urgent risk to global human health. CRE that are non-susceptible to all commercially available antibiotics threaten to return us to the pre-antibiotic era. Using Single Molecule Real Time (SMRT) sequencing we determined the complete genome of a pandrug-resistant Klebsiella pneumoniae isolate, representing the first complete genome sequence of CRE resistant to all commercially available antibiotics. The precise location of acquired antibiotic resistance elements, including mobile elements carrying genes for the OXA-181 carbapenemase, were defined. Intriguingly, we identified three chromosomal copies of an ISEcp1-bla(OXA-181) mobile element, one of which has disrupted the mgrB regulatory gene, accounting for resistance to colistin. Our findings provide the first description of pandrug-resistant CRE at the genomic level, and reveal the critical role of mobile resistance elements in accelerating the emergence of resistance to other last resort antibiotics.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.